Skip to main content
. 2021 Dec 14;8:762570. doi: 10.3389/fmed.2021.762570

Figure 7.

Figure 7

Comparisons of the expression levels of immunotherapy and targeted therapy target genes between high- and low-risk subgroups. The platelet-derived growth factor receptor beta (PDGFRB), programmed cell death 1 (PDCD1), and KIT proto-oncogene (KIT) expression levels were higher in the high-risk group, while the FLT3 and FLT4 expressions were higher in the low-risk group. *p < 0.050, **p < 0.010, and ***p < 0.001; ns, no significance.